TY - JOUR
T1 - Differential IL-12 signaling induces human natural killer cell activating receptor-mediated ligand-specific expansion
AU - Shemesh, Avishai
AU - Pickering, Harry
AU - Roybal, Kole T.
AU - Lanier, Lewis L.
N1 - Funding Information:
Studies were supported by National Institutes of Health grants AI068129 and U19AI128913, the Parker Institute for Cancer Immunotherapy, the Irvington Cancer Research Institute Fellowship to A. Shemesh, and the UCSF Parnassus Flow Core (RRID: SCR_018206).
Funding Information:
We thank the Lanier and Roybal lab members for their input during the conduction of this research and the University of California, Los Angeles Systems Immunobiology Group for providing cytokine data from the kidney patient cohort.
Publisher Copyright:
© 2022 Shemesh et al.
PY - 2022/8/1
Y1 - 2022/8/1
N2 - IL-12 is an essential cytokine involved in the generation of memory or memory-like NK cells. Mouse cytomegalovirus infection triggers NK receptor-induced, ligand-specific IL-12–dependent NK cell expansion, yet specific IL-12 stimulation ex vivo leading to NK cell proliferation and expansion is not established. Here, we show that IL-12 alone can sustain human primary NK cell survival without providing IL-2 or IL-15 but was insufficient to promote human NK cell proliferation. IL-12 signaling analysis revealed STAT5 phosphorylation and weak mTOR activation, which was enhanced by activating NK receptor upregulation and crosslinking leading to STAT5-dependent, rapamycin-sensitive, or TGFβ-sensitive NK cell IL-12–dependent expansion, independently of IL-12 receptor upregulation. Prolonged IL-2 culture did not impair IL-12–dependent ligand-specific NK cell expansion. These findings demonstrate that activating NK receptor stimulation promotes differential IL-12 signaling, leading to human NK cell expansion, and suggest adopting strategies to provide IL-12 signaling in vivo for ligand-specific IL-2–primed NK cell–based therapies.
AB - IL-12 is an essential cytokine involved in the generation of memory or memory-like NK cells. Mouse cytomegalovirus infection triggers NK receptor-induced, ligand-specific IL-12–dependent NK cell expansion, yet specific IL-12 stimulation ex vivo leading to NK cell proliferation and expansion is not established. Here, we show that IL-12 alone can sustain human primary NK cell survival without providing IL-2 or IL-15 but was insufficient to promote human NK cell proliferation. IL-12 signaling analysis revealed STAT5 phosphorylation and weak mTOR activation, which was enhanced by activating NK receptor upregulation and crosslinking leading to STAT5-dependent, rapamycin-sensitive, or TGFβ-sensitive NK cell IL-12–dependent expansion, independently of IL-12 receptor upregulation. Prolonged IL-2 culture did not impair IL-12–dependent ligand-specific NK cell expansion. These findings demonstrate that activating NK receptor stimulation promotes differential IL-12 signaling, leading to human NK cell expansion, and suggest adopting strategies to provide IL-12 signaling in vivo for ligand-specific IL-2–primed NK cell–based therapies.
UR - http://www.scopus.com/inward/record.url?scp=85132956269&partnerID=8YFLogxK
U2 - 10.1084/jem.20212434
DO - 10.1084/jem.20212434
M3 - Article
C2 - 35758909
AN - SCOPUS:85132956269
SN - 0022-1007
VL - 219
JO - Journal of Experimental Medicine
JF - Journal of Experimental Medicine
IS - 8
M1 - e20212434
ER -